«The challenge is finding targets that exist on other types of cancer cells but not on normal cells,» says
pediatric oncologist Stephan Grupp of the Children's Hospital of Philadelphia, who worked with Porter on testing the treatment in mice.
«It's a completely different way of treating cancer,» says
pediatric oncologist Stephan Grupp, who directs the Cancer Immunotherapy Program at the Children's Hospital of Philadelphia.
Not exact matches
asks
Stephan Grupp, a
pediatric oncologist at the Children's Hospital of Philadelphia (CHOP) in Pennsylvania.